- Home
- KLTO vs CELZ Comparison
KLTO vs CELZ Comparison
Compare KLTO & CELZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KLTO
- CELZ
- Stock Information
- Founded
- KLTO 2019
- CELZ 1998
- Country
- KLTO United States
- CELZ United States
- Employees
- KLTO N/A
- CELZ N/A
- Industry
- KLTO
- CELZ Biotechnology: Pharmaceutical Preparations
- Sector
- KLTO
- CELZ Health Care
- Exchange
- KLTO NYSE
- CELZ Nasdaq
- Market Cap
- KLTO 5.0M
- CELZ 5.5M
- IPO Year
- KLTO N/A
- CELZ N/A
- Fundamental
- Price
- KLTO $0.16
- CELZ $1.93
- Analyst Decision
- KLTO
- CELZ
- Analyst Count
- KLTO 0
- CELZ 0
- Target Price
- KLTO N/A
- CELZ N/A
- AVG Volume (30 Days)
- KLTO 152.3K
- CELZ 100.5K
- Earning Date
- KLTO 05-15-2025
- CELZ 05-09-2025
- Dividend Yield
- KLTO N/A
- CELZ N/A
- EPS Growth
- KLTO N/A
- CELZ N/A
- EPS
- KLTO N/A
- CELZ N/A
- Revenue
- KLTO N/A
- CELZ $11,000.00
- Revenue This Year
- KLTO N/A
- CELZ N/A
- Revenue Next Year
- KLTO N/A
- CELZ N/A
- P/E Ratio
- KLTO N/A
- CELZ N/A
- Revenue Growth
- KLTO N/A
- CELZ 22.22
- 52 Week Low
- KLTO $0.11
- CELZ $1.69
- 52 Week High
- KLTO $13.10
- CELZ $6.90
- Technical
- Relative Strength Index (RSI)
- KLTO N/A
- CELZ 38.56
- Support Level
- KLTO N/A
- CELZ $1.90
- Resistance Level
- KLTO N/A
- CELZ $2.10
- Average True Range (ATR)
- KLTO 0.00
- CELZ 0.24
- MACD
- KLTO 0.00
- CELZ 0.06
- Stochastic Oscillator
- KLTO 0.00
- CELZ 36.49
About KLTO KLOTHO NEUROSCIENCES INC
Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.